Richard B. Lock

14.0k total citations
260 papers, 8.7k citations indexed

About

Richard B. Lock is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Richard B. Lock has authored 260 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Molecular Biology, 90 papers in Public Health, Environmental and Occupational Health and 78 papers in Oncology. Recurrent topics in Richard B. Lock's work include Acute Lymphoblastic Leukemia research (86 papers), Neuroblastoma Research and Treatments (46 papers) and Acute Myeloid Leukemia Research (36 papers). Richard B. Lock is often cited by papers focused on Acute Lymphoblastic Leukemia research (86 papers), Neuroblastoma Research and Treatments (46 papers) and Acute Myeloid Leukemia Research (36 papers). Richard B. Lock collaborates with scholars based in Australia, United States and United Kingdom. Richard B. Lock's co-authors include Malcolm A. Smith, Peter J. Houghton, C. Patrick Reynolds, Hernán Carol, Warren E. Ross, John M. Maris, Stephen T. Keir, E. Anders Kolb, Richard Görlick and Christopher L. Morton and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Richard B. Lock

247 papers receiving 8.6k citations

Peers

Countries citing papers authored by Richard B. Lock

Since Specialization

Citations

This map shows the geographic impact of Richard B. Lock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Lock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Lock more than expected).

Fields of papers citing papers by Richard B. Lock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Lock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Lock. The network helps show where Richard B. Lock may publish in the future.

Co-authorship network of co-authors of Richard B. Lock

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Lock. A scholar is included among the top collaborators of Richard B. Lock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Lock. Richard B. Lock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia 2023 ·International Journal of Biological Macromolecules ·(unknown), Peter Schofield, Hannah McCalmont, Ernest Moles, Karlheinz Friedrich, Maria Kavallaris, Daniel Christ, Narges Bayat, Richard B. Lock	4
2	Targeting TSLP-Induced Tyrosine Kinase Signaling Pathways in CRLF2 -Rearranged Ph-like ALL 2020 ·Molecular Cancer Research ·(unknown), Ling Zhong, Chelsea Mayoh, Murray D. Norris, Michelle Haber, Glenn M. Marshall, Mark J. Raftery, Richard B. Lock	2
3	PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis 2020 ·Molecular Cancer Therapeutics ·(unknown), Neha Singh, (unknown), Valerie Calvert, Emanuel F. Petricoin, David T. Teachey, Richard B. Lock, (unknown), Andrew S. Kraft, Sathish K.R. Padi	4
4	A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921) 2019 ·Clinical Cancer Research ·Yaël P. Mossé, Elizabeth Fox, David T. Teachey, Joel M. Reid, Stephanie L. Safgren, Hernán Carol, Richard B. Lock, Peter J. Houghton, Malcolm A. Smith, David Hall, Donald A. Barkauskas, Mark Krailo, Stephan D. Voss, Stacey L. Berg, Susan M. Blaney, Brenda J. Weigel	79
5	Bioluminescence Imaging Enhances Analysis of Drug Responses in a Patient-Derived Xenograft Model of Pediatric ALL 2017 ·Clinical Cancer Research ·(unknown), Jennifer Richmond, Kathryn Evans, Hernán Carol, Duohui Jing, Raushan T. Kurmasheva, Catherine A. Billups, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock	17
6	Acute Sensitivity of Ph-like Acute Lymphoblastic Leukemia to the SMAC-Mimetic Birinapant 2016 ·Cancer Research ·Jennifer Richmond, Alissa K. Robbins, Kathryn Evans, Dominik Beck, Raushan T. Kurmasheva, Catherine A. Billups, Hernán Carol, Susan L. Heatley, Rosemary Sutton, Glenn M. Marshall, Deborah L. White, John E. Pimanda, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock	18
7	Evaluation of Alternative In Vivo Drug Screening Methodology: A Single Mouse Analysis 2016 ·Cancer Research ·Brendan Murphy, (unknown), John M. Maris, E. Anders Kolb, Richard Görlick, C. Patrick Reynolds, Min H. Kang, Stephen T. Keir, Raushan T. Kurmasheva, Igor Dvorchik, Jianrong Wu, Catherine A. Billups, (unknown), Malcolm A. Smith, Richard B. Lock, Peter J. Houghton	40
8	The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects 2016 ·Clinical Cancer Research ·Jeyran Shahbazi, (unknown), Bernard Atmadibrata, James E. Bradner, Glenn M. Marshall, Richard B. Lock, Tao Liu	101
9	Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia 2016 ·Cancer Research ·Sibasish Dolai, (unknown), Alissa K. Robbins, Ling Zhong, Susan L. Heatley, Tiffaney L. Vincent, Falko Hochgräfe, Rosemary Sutton, Raushan T. Kurmasheva, Tamás Révész, Deborah L. White, Peter J. Houghton, Malcolm A. Smith, David T. Teachey, Roger J. Daly, Mark J. Raftery, Richard B. Lock	12
10	Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia 2016 ·Blood ·Seong Lin Khaw, Santi Suryani, Kathryn Evans, Jennifer Richmond, Alissa K. Robbins, Raushan T. Kurmasheva, Catherine A. Billups, Stephen W. Erickson, Yuelong Guo, Peter J. Houghton, Malcolm A. Smith, Hernán Carol, Andrew W. Roberts, David C.S. Huang, Richard B. Lock	112
11	The CDK9 Inhibitor Dinaciclib Exerts Potent Apoptotic and Antitumor Effects in Preclinical Models of MLL-Rearranged Acute Myeloid Leukemia 2015 ·Cancer Research ·Adele Baker, Gareth P. Gregory, Inge Verbrugge, Lev M. Kats, (unknown), Eva Vidacs, Erwin M. Lee, Richard B. Lock, Johannes Zuber, Jake Shortt, Ricky W. Johnstone	83
12	Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL -Rearranged Acute Lymphoblastic Leukemia 2015 ·Clinical Cancer Research ·Jennifer Richmond, Hernán Carol, Kathryn Evans, (unknown), (unknown), Alissa K. Robbins, Claus Meyer, Nicola C. Venn, Rolf Marschalek, Michelle J. Henderson, Rosemary Sutton, Raushan T. Kurmasheva, Ursula R. Kees, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock	41
13	Evaluation of the In Vitro and In Vivo Efficacy of the JAK Inhibitor AZD1480 against JAK-Mutated Acute Lymphoblastic Leukemia 2014 ·Molecular Cancer Therapeutics ·Santi Suryani, (unknown), Richard C. Harvey, (unknown), Hernán Carol, I‐Ming Chen, Kathryn Evans, (unknown), Kathryn G. Roberts, Raushan T. Kurmasheva, Catherine A. Billups, Charles G. Mullighan, Cheryl L. Willman, Mignon L. Loh, Stephen P. Hunger, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock	43
14	Synergistic Activity of PARP Inhibition by Talazoparib (BMN 673) with Temozolomide in Pediatric Cancer Models in the Pediatric Preclinical Testing Program 2014 ·Clinical Cancer Research ·Malcolm A. Smith, C. Patrick Reynolds, Min H. Kang, E. Anders Kolb, Richard Görlick, Hernán Carol, Richard B. Lock, Stephen T. Keir, John M. Maris, Catherine A. Billups, Dmitry Lyalin, Raushan T. Kurmasheva, Peter J. Houghton	90
15	The Anti-CD19 Antibody–Drug Conjugate SAR3419 Prevents Hematolymphoid Relapse Postinduction Therapy in Preclinical Models of Pediatric Acute Lymphoblastic Leukemia 2013 ·Clinical Cancer Research ·Hernán Carol, Barbara Szymanska, Kathryn Evans, Ingrid Boehm, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock	57
16	Induction of Vascular Endothelial Growth Factor Secretion by Childhood Acute Lymphoblastic Leukemia Cells via the FLT-3 Signaling Pathway 2011 ·Molecular Cancer Therapeutics ·Ana Marković, Karen L. MacKenzie, Richard B. Lock	12
17	Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program 2010 ·Molecular Cancer Therapeutics ·Peter J. Houghton, Christopher L. Morton, Richard Görlick, Richard B. Lock, Hernán Carol, C. Patrick Reynolds, Min H. Kang, John M. Maris, Stephen T. Keir, E. Anders Kolb, (unknown), Amy Wozniak, Catherine A. Billups, Larry Rubinstein, Malcolm A. Smith	79
18	Molecular Characterization of the Pediatric Preclinical Testing Panel 2008 ·Clinical Cancer Research ·Geoffrey Neale, Xiaoping Su, Christopher L. Morton, Doris A. Phelps, Richard Görlick, Richard B. Lock, C. Patrick Reynolds, John M. Maris, Henry S. Friedman, Jeffrey S. Dome, Joseph D. Khoury, Timothy J. Triche, Robert C. Seeger, Richard J. Gilbertson, Javed Khan, Malcolm A. Smith, Peter J. Houghton	95
19	Credentialing Preclinical Pediatric Xenograft Models Using Gene Expression and Tissue Microarray Analysis 2007 ·Cancer Research ·Craig C. Whiteford, Sven Bilke, Braden T. Greer, Qingrong Chen, Till Braunschweig, (unknown), Jun S. Wei, Malcolm A. Smith, Peter J. Houghton, Christopher L. Morton, C. Patrick Reynolds, Richard B. Lock, Richard Görlick, Chand Khanna, Carol J. Thiele, Mikiko Takikita, Daniel Catchpoole, Stephen M. Hewitt, Javed Khan	91
20	Divergent Mechanisms of Glucocorticoid Resistance in Experimental Models of Pediatric Acute Lymphoblastic Leukemia 2007 ·Cancer Research ·Petra Bachmann, (unknown), Rachael A. Papa, (unknown), Jette Ford, Ursula R. Kees, Glenn M. Marshall, Richard B. Lock	98

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact